NCT02654236View on ClinicalTrials.gov

Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Alcohol Consumption
Interventions
DRUG

Placebo

1 tablet of placebo, taken orally daily with water, approximately 30 minutes prior to breakfast for 4 weeks.

DRUG

10 mg Obeticholic Acid (OCA)

10 mg Obeticholic Acid (OCA) Study medication will be administered orally, once daily, approximately 30 minutes prior to breakfast for 4 weeks.

Trial Locations (1)

46202

Indiana University, Indianapolis

Sponsors

Collaborators (1)

Intercept Pharmaceuticals
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

collaborator

Intercept Pharmaceuticals

INDUSTRY

lead

Suthat Liangpunsakul

OTHER